Drug Markets/Dapagliflozin and Metformin Hydrochloride

Dapagliflozin and Metformin Hydrochloride

7 NDCs across 2 manufacturers|2 Generic,5 Brand

▸ More about this market

Dapagliflozin and Metformin Hydrochloride is available as 7 NDCs from 2 manufacturers (2 generic, 5 brand), with NADAC prices from $0.46 to $19.24 per EA — the most expensive product costs about 42× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

7

2G / 5B

Manufacturers

2

competing in market

Price Spread

$0.46 – $19.24

per EA

7d Activity

8↑2↓-3 flat

avg +0.0% WoW · of 7 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

2 manufacturers producing DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Frequently Asked Questions

How many Dapagliflozin and Metformin Hydrochloride products are on the market?

The Dapagliflozin and Metformin Hydrochloride drug market contains 7 NDCs from 2 manufacturers — 2 generic and 5 brand products.

What is the price range for Dapagliflozin and Metformin Hydrochloride?

NADAC reference prices for Dapagliflozin and Metformin Hydrochloride range from $0.4606 to $19.2391 per EA — the most expensive product costs about 42× the cheapest.

Is generic Dapagliflozin and Metformin Hydrochloride cheaper than brand?

The average generic NADAC for Dapagliflozin and Metformin Hydrochloride is $0.5901 per EA, versus $15.3651 for brand-labeled products — brand versions average about 26× the generic price.

Which manufacturers make Dapagliflozin and Metformin Hydrochloride?

2 manufacturers list Dapagliflozin and Metformin Hydrochloride in NADAC. Ranked by number of NDCs, the largest are AstraZeneca Pharmaceuticals LP (5), Prasco Laboratories (2).

How has the price of Dapagliflozin and Metformin Hydrochloride changed recently?

Over the past 7 days, 8 Dapagliflozin and Metformin Hydrochloride NDCs rose and 2 fell, with a market-wide average change of +0.0%.